Picard Medical (NYSE: PMI) outlines NYSE opening bell appearance

Rhea-AI Filing Summary

Picard Medical, Inc. filed a current report to note that members of its management team will ring the opening bell at the New York Stock Exchange. The company issued a press release about this event on December 18, 2025 and furnished it as Exhibit 99.1.

The company states that the information in this report and its exhibits is being furnished, not filed, so it is not subject to Exchange Act filing liabilities and is not automatically incorporated by reference into other securities-law filings.

false 0002030617 0002030617 2025-12-18 2025-12-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 18, 2025

Picard Medical, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-42801		86-3212894
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1992 E Silverlake
Tucson AZ, 85713

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (520) 545-1234

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		PMI		The NYSE American, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

On December 18, 2025, Picard Medical, Inc. issued a press release announcing that members of its management team will ring the opening bell at the New York Stock Exchange. A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference herein.

The information in this report and the exhibits attached hereto shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are being filed herewith:

Exhibit No.		Description
99.1		Picard Medical, Inc. Press Release dated December 18, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Picard Medical, Inc.
	By:	/s/ Patrick NJ Schnegelsberg
		Name:	Patrick NJ Schnegelsberg
		Title:	Chief Executive Officer

Dated: December 18, 2025

2

FAQ

What did Picard Medical (PMI) disclose in this SEC current report?

Picard Medical disclosed that members of its management team will ring the opening bell at the New York Stock Exchange and that it issued a press release about this event on December 18, 2025, which is furnished as Exhibit 99.1.

What is Exhibit 99.1 in Picard Medical (PMI)'s December 18, 2025 filing?

Exhibit 99.1 is a Picard Medical, Inc. press release dated December 18, 2025 describing that members of the company's management team will ring the opening bell at the New York Stock Exchange.

Is the information about Picard Medical (PMI)'s NYSE opening bell event considered filed with the SEC?

No. The company states that the information in this report and the attached exhibits is furnished, not filed, so it is not subject to the liabilities of Section 18 of the Exchange Act and is not deemed incorporated by reference into other Securities Act or Exchange Act filings.

Does this Picard Medical (PMI) report describe any financial results or major transactions?

No. The report focuses on a ceremonial event in which members of Picard Medical's management team will ring the opening bell at the New York Stock Exchange and references the related press release.

Who signed Picard Medical (PMI)'s December 18, 2025 current report?

The report was signed on behalf of Picard Medical, Inc. by Patrick NJ Schnegelsberg, who is identified as the company’s Chief Executive Officer.